American Portfolios Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $50.8K | Hold |
44,939
| – | – | ﹤0.01% | 1693 |
|
|
2022
Q2 | $71K | Hold |
44,939
| – | – | ﹤0.01% | 1579 |
|
|
2022
Q1 | $69.2K | Sell |
44,939
-8,345
| -16% | -$12.9K | ﹤0.01% | 1726 |
|
|
2021
Q4 | $131K | Sell |
53,284
-20
| -0% | -$49 | ﹤0.01% | 1381 |
|
|
2021
Q3 | $134K | Hold |
53,304
| – | – | 0.01% | 1317 |
|
|
2021
Q2 | $152K | Hold |
53,304
| – | – | 0.01% | 1237 |
|
|
2021
Q1 | $125K | Buy |
53,304
+41,600
| +355% | +$97.8K | 0.01% | 1235 |
|
|
2020
Q4 | $20.6K | Sell |
11,704
-1,814
| -13% | -$3.19K | ﹤0.01% | 1803 |
|
|
2020
Q3 | $12.7K | Buy |
13,518
+13,504
| +96,457% | +$12.6K | ﹤0.01% | 1885 |
|
|
2020
Q2 | $12 | Hold |
14
| – | – | ﹤0.01% | 2835 |
|
|
2020
Q1 | $12 | Hold |
14
| – | – | ﹤0.01% | 2763 |
|
|
2019
Q4 | $12 | Hold |
14
| – | – | ﹤0.01% | 2836 |
|
|
2019
Q3 | $14 | Hold |
14
| – | – | ﹤0.01% | 2819 |
|
|
2019
Q2 | $15 | Hold |
14
| – | – | ﹤0.01% | 2717 |
|
|
2019
Q1 | $18 | Buy |
+14
| New | +$18 | ﹤0.01% | 2600 |
|